In this ciclopropilamida discloses at least a Derivative of formula (i), wherein R1 is aryl, heteroaryl, heterocycle, cyano, among others R2 is alkyl or cycloalkyl - C1 - C6 and C6 C3, R3, R4, R5, R6, R7, R8, R9 and R10 is H, alkyl C1 - C3.Also disclosed is a Pharmaceutical composition comprising at least one of the disclosed here ciclopropilamida derivative and at least one method to use at least a Derivative of ciclopropilamida here disclosed for the treatment of at least a condition linked to the H3 Receptor HistamineEn la presente se divulga al menos un derivado de ciclopropilamida de formula (I), en donde R1 es arilo, heteroarilo, heterociclo, ciano, entre otros R2 es alquilo C1-C6 o cicloalquilo C3-C6 y R3, R4, R5, R6, R7, R8, R9 y R10 son H, alquilo C1-C3. Tambien se divulga al menos una composicion farmaceutica que comprende al menos un derivado de ciclopropilamida de los aqui divulgados y al menos un metodo para utilizar al menos un derivado de ciclopropilamida aqui divulgado para el tratamiento de al menos una afeccion vinculada al receptor H3 de la histamina
